盛美上海(688082.SH):擬投資建設高端半導體設備拓展研發項目
格隆匯8月7日丨盛美上海(688082.SH)公佈,新項目名稱:高端半導體設備拓展研發項目。
投資金額及資金來源:該項目計劃總投資74773.07萬元,其中,場地投資46750.25萬元,研發設備購置及安裝費2070.30萬元,研發費用25952.52萬元。該項目投資資金中,公司使用自有資金投入1685.91萬元,剩餘73087.15萬元擬使用公司首發上市超募資金投入建設。
公司於2022年8月4日召開第一屆董事會第十九次會議及第一屆監事會第十六次會議,審議通過《關於使用部分超募資金投資建設新項目的議案》,同意公司使用74773.07萬元(含利息收益)用於投資建設新項目,其中使用超募資金人民幣73087.15萬元。上述事項尚需提交公司股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.